Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
113.00    1.50 (1.35%)
Bid:
112.00
Ask:
114.00
Spread: 2.00 (1.786%)
Market Cap: £67.98m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Contract Win

9 May 2017 07:00

RNS Number : 5193E
Intercede Group PLC
09 May 2017
 

 

9 May 2017

INTERCEDE GROUP plc

("Intercede", or the "Group")

Contract Win

Intercede, the leading specialist in digital identity, credential management and secure mobility, today announces further progress in securing contract wins from its pipeline with the award of a MyID contract from a major US aerospace and defence contractor.

Under this contract, Intercede's MyID platform will be used to issue and manage digital credentials for more than 100,000 entities including employees, computers and other devices. The supply chain for this project is through a long standing Intercede ecosystem partner and is expected to generate approximately US$1.0 million of revenue over the next five years.

This further contract win follows the 5 April 2017 announcement that Intercede had secured MyID contract wins with a major US Federal Agency and a US based world leader in medical care, research and education. In combination, it is expected that these previously announced wins will generate revenue for the Group of US$1.5 million over the next five years.

In full deployment, the Federal Agency agreement will encompass approximately 100,000 employees distributed across 300 physical facilities around the world. The first phase covers 60% of the workforce who need to use digital credentials to secure access to government networks and information assets. Within the healthcare organisation, MyID will be used to issue cryptographic tokens to enable secure network access for up to 60,000 people.

Commenting on the Group's progress, Richard Parris, Chairman and Chief Executive of Intercede, said;

"It is pleasing to report further progress in securing important contract wins within our core markets. The most recent award supports our view that the provision of digital trust is increasingly required by a range of critical industries where legacy password authentication systems will be replaced by digital provision. Led by the Government, emerging US best practice is expanding the addressable market place for the MyID platform into critical industries such as healthcare in addition to our core aerospace and defence base. I am particularly pleased that Intercede has won these contracts in partnership with significant participants in the digital security space. Our ability to work with these companies and to embed our solutions within vital ecosystems provides a strong proof of concept for potential customers in new geographies and industries."

-ENDS-

 

Contact

Intercede Group plc

Tel: +44 (0) 1455 558 111

Richard Parris

Chairman & Chief Executive

Andrew Walker

Finance Director

finnCap

Tel: +44 (0) 20 7220 0500

Stuart Andrews

Corporate Finance

Simon Hicks

Corporate Finance

Capital Access Group

Tel: +44 (0) 20 3763 3400

Scott Fulton

Media

Ed Welsby

Investors

 

About Intercede

Intercede® is a cybersecurity company specializing in identity, credential management and secure mobility to enable digital trust. It provides software and services that help organizations ensure the safety and security of their people, facilities, networks and information in an increasingly mobile, digital world.

Intercede has been delivering solutions to high profile customers, from the US and UK governments to some of the world's largest corporations, telecommunications providers and information technology firms, for over 20 years. To find out more: www.intercede.com

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTUWONRBAAVRAR
Date   Source Headline
20th May 20267:00 amRNS-RPartnership with OneSpan
19th May 20267:00 amRNSNotice of Results and Investor Presentation
11th May 20262:50 pmRNSShare Incentive Scheme
21st Apr 20267:00 amRNSNew Contract Upsell Orders and Renewal
9th Apr 20267:00 amRNSTrading Update, Renewals and New Contract Orders
17th Mar 20267:00 amRNSYear End Trading Update
17th Mar 20267:00 amRNSYear End Trading Update
9th Feb 202612:55 pmRNSHolding(s) in Company
15th Jan 202610:44 amRNSExercise of Options & Total Voting Rights
24th Dec 20257:00 amRNSExercise of Options & Total Voting Rights
2nd Dec 20251:05 pmRNSHolding(s) in Company
25th Nov 20257:01 amRNSNew Contract Awards and Renewals
25th Nov 20257:00 amRNSHalf-year Report
22nd Oct 20252:15 pmRNSNotice of Interim Results & Investor Presentation
13th Oct 20257:00 amRNSExercise of Options, PDMR Shareholding & TVR
10th Oct 202510:25 amRNSDirector/PDMR Shareholding
9th Oct 20251:02 pmRNSDirector/PDMR Shareholding
9th Oct 20257:00 amRNSTrading Update, New Contract awards and Renewals
25th Sep 20251:03 pmRNSResult of AGM
22nd Sep 20257:00 amRNSNon-Executive Director Change
22nd Aug 20257:00 amRNSIssue of Equity & Total Voting Rights
12th Aug 20257:00 amRNSNotice of AGM and release of Annual Report 2025
24th Jul 20257:00 amRNS-RFirst CMS to support FIDO enterprise attestation
22nd Jul 20257:00 amRNSGrowth Share Scheme Vesting and Award Allocation
3rd Jul 20257:00 amRNSNew Contract Orders and Renewals
25th Jun 20256:01 pmRNSDirector/PDMR Shareholding
25th Jun 20257:00 amRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSFinal Results
22nd May 20253:14 pmRNSNotice of Results & Investor Presentation
7th May 20257:00 amRNSShare Incentive Scheme
1st May 20257:00 amRNS-RIntercede Collaborates with Microsoft and Yubico
8th Apr 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSMomentum maintained with New Contract Orders
31st Mar 202511:48 amRNSHolding(s) in Company
12th Mar 20251:54 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSContinued Momentum with New Contract Orders
8th Jan 20257:00 amRNSContract Orders and Renewals
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
19th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSTransaction in Own Shares
11th Dec 20247:00 amRNSTransaction in Own Shares
10th Dec 20247:00 amRNSTransaction in Own Shares
5th Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20247:00 amRNSTransaction in Own Shares
29th Nov 20247:00 amRNSTransaction in Own Shares
28th Nov 20247:00 amRNSTransaction in Own Shares
27th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSTransaction in Own Shares
26th Nov 20247:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.